wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52571134-B55B86D5-DF6C-43E6-B205-01EA139667AE
Q52571134-B55B86D5-DF6C-43E6-B205-01EA139667AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52571134-B55B86D5-DF6C-43E6-B205-01EA139667AE
Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia.
P2860
Q52571134-B55B86D5-DF6C-43E6-B205-01EA139667AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52571134-B55B86D5-DF6C-43E6-B205-01EA139667AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f168b3c710cfa9520e350265cfa8781b9c447b0
P2860
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.